D.E. Shaw & Co’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Buy |
487,672
+336,030
| +222% | +$1.29M | ﹤0.01% | 1940 |
|
|
2025
Q1 | $872K | Sell |
151,642
-36,941
| -20% | -$212K | ﹤0.01% | 2233 |
|
|
2024
Q4 | $941K | Sell |
188,583
-146,198
| -44% | -$730K | ﹤0.01% | 2137 |
|
|
2024
Q3 | $1.8M | Buy |
334,781
+12,843
| +4% | +$69.2K | ﹤0.01% | 1844 |
|
|
2024
Q2 | $1.07M | Sell |
321,938
-225,702
| -41% | -$747K | ﹤0.01% | 2157 |
|
|
2024
Q1 | $1.79M | Buy |
547,640
+287,584
| +111% | +$940K | ﹤0.01% | 1843 |
|
|
2023
Q4 | $913K | Buy |
260,056
+214,089
| +466% | +$751K | ﹤0.01% | 2113 |
|
|
2023
Q3 | $307K | Sell |
45,967
-30,013
| -40% | -$200K | ﹤0.01% | 2459 |
|
|
2023
Q2 | $637K | Sell |
75,980
-48,942
| -39% | -$411K | ﹤0.01% | 2254 |
|
|
2023
Q1 | $1.24M | Sell |
124,922
-222,947
| -64% | -$2.21M | ﹤0.01% | 2076 |
|
|
2022
Q4 | $2.42M | Sell |
347,869
-100,241
| -22% | -$698K | ﹤0.01% | 1927 |
|
|
2022
Q3 | $2.39M | Buy |
448,110
+174,769
| +64% | +$933K | ﹤0.01% | 2003 |
|
|
2022
Q2 | $1.09M | Buy |
273,341
+34,183
| +14% | +$136K | ﹤0.01% | 2647 |
|
|
2022
Q1 | $1.06M | Buy |
239,158
+202,930
| +560% | +$902K | ﹤0.01% | 2833 |
|
|
2021
Q4 | $145K | Buy |
36,228
+21,947
| +154% | +$87.8K | ﹤0.01% | 3576 |
|
|
2021
Q3 | $125K | Sell |
14,281
-942
| -6% | -$8.25K | ﹤0.01% | 3354 |
|
|
2021
Q2 | $172K | Sell |
15,223
-2,929
| -16% | -$33.1K | ﹤0.01% | 3264 |
|
|
2021
Q1 | $216K | Buy |
+18,152
| New | +$216K | ﹤0.01% | 2764 |
|
|
2019
Q4 | – | Sell |
-18,111
| Closed | -$95K | – | 2621 |
|
|
2019
Q3 | $95K | Buy |
18,111
+7,007
| +63% | +$36.8K | ﹤0.01% | 2459 |
|
|
2019
Q2 | $67K | Buy |
+11,104
| New | +$67K | ﹤0.01% | 2510 |
|